A detailed history of Gps Wealth Strategies Group, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Gps Wealth Strategies Group, LLC holds 2,830 shares of LLY stock, worth $2.12 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares
2,830
Previous 2,821 0.32%
Holding current value
$2.12 Million
Previous $2.55 Million 1.84%
% of portfolio
0.35%
Previous 0.39%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$772.14 - $960.02 $6,949 - $8,640
9 Added 0.32%
2,830 $2.51 Million
Q2 2024

Jul 16, 2024

BUY
$724.87 - $909.04 $137,725 - $172,717
190 Added 7.22%
2,821 $2.55 Million
Q1 2024

Apr 30, 2024

SELL
$592.2 - $792.28 $164,039 - $219,461
-277 Reduced 9.53%
2,631 $2.05 Million
Q4 2023

Jan 12, 2024

BUY
$525.19 - $619.13 $410,173 - $483,540
781 Added 36.72%
2,908 $1.7 Million
Q3 2023

Oct 25, 2023

BUY
$434.7 - $599.3 $126,497 - $174,396
291 Added 15.85%
2,127 $1.14 Million
Q2 2023

Jul 17, 2023

BUY
$350.74 - $468.98 $357,053 - $477,421
1,018 Added 124.45%
1,836 $861,000
Q1 2023

Apr 17, 2023

BUY
$310.63 - $364.82 $254,095 - $298,422
818 New
818 $280,000
Q3 2022

Oct 17, 2022

BUY
$296.48 - $337.87 $11,859 - $13,514
40 Added 8.42%
515 $167,000
Q2 2022

Jul 19, 2022

BUY
$278.73 - $327.27 $16,445 - $19,308
59 Added 14.18%
475 $154,000
Q1 2022

Apr 20, 2022

SELL
$234.69 - $291.66 $23,703 - $29,457
-101 Reduced 19.54%
416 $119,000
Q4 2021

Feb 11, 2022

SELL
$224.85 - $279.04 $33,052 - $41,018
-147 Reduced 22.14%
517 $143,000
Q3 2021

Oct 20, 2021

BUY
$221.6 - $272.71 $4,432 - $5,454
20 Added 3.11%
664 $153,000
Q2 2021

Jul 19, 2021

SELL
$180.55 - $233.54 $722 - $934
-4 Reduced 0.62%
644 $148,000
Q1 2021

Apr 15, 2021

BUY
$164.32 - $212.72 $106,479 - $137,842
648 New
648 $121,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $713B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Gps Wealth Strategies Group, LLC Portfolio

Follow Gps Wealth Strategies Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gps Wealth Strategies Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gps Wealth Strategies Group, LLC with notifications on news.